Vidaza
(vih-DAY-zuh)
A drug that contains the active ingredient azacitidine and is used to treat adults with certain types of myelodysplastic syndromes and children aged 1 month and older with newly diagnosed juvenile myelomonocytic leukemia. It is also being studied in the treatment of other types of cancer. Vidaza stops cells from making DNA and may kill cancer cells. It is a type of antimetabolite.